DarioHealth Corp Selected Fundamentals

DRIO -- USA Stock  

USD 1.00  0.02  2.04%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
DarioHealth Corp 
MV Per Share 
Revenue Per Share 
4.18 times

DarioHealth Corp Distress Driver Correlations

Price to Sales Pattern

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont return on equity.
 Return on Sales 

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

DarioHealth Corp Price to Sales Assessment


DarioHealth Corp Sales Growth Over Time

Return on Sales

Sales per Share

Based on latest financial disclosure the price to sales indicator of DarioHealth Corp is roughly 4.18 times. This is 80.44% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Price to Sales for all stocks is 76.53% higher than the company.

DarioHealth Corp Fundamental Drivers Relationships

DarioHealth Corp is rated # 4 in cash and equivalents category among related companies. It is rated below average in price to book category among related companies . The ratio of Cash and Equivalents to Price to Book for DarioHealth Corp is about  2,582,143 

Did you try this?

Run Idea Optimizer Now


Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Idea Optimizer
As returns on market increase, DarioHealth Corp returns are expected to increase less than the market. However during bear market, the loss on holding DarioHealth Corp will be expected to be smaller as well.

Search macroaxis.com